 |
BioWorld-International-2006-02-08
Pharming Gets Up To $30M Via Paul Royalty Fund Deal
Pharming Gets Up To $30M Via Paul Royalty Fund Deal
Just one week after taking in €17.1 million (US$20.6 million) in a private placing, Pharming Group NV banked another $18.5 million as part of a royalty agreement with Paul Royalty Fund that could be worth up to $30 million in total. (BioWorld International)